bpc-157 human clinical evidence tendon healing randomized trial BPC-157: What the Science Actually Says Gastric pentadecapeptide BPC 157 accelerates
Description
Maintenance Therapy: Once the big dose is done, smaller doses are given every 1-3 months
doi: 10.1300/J092v08n03_10 352 KennedyGNorrisGSpenceVMcLarenMBelchJJ
A common knee-focused stack: BPC-157: 250 mcg twice daily, injected subcutaneously near the knee TB-500: 2-2.5 mg twice per week, injected subcutaneously (abdomen or near knee) TB-500 works systemically due to its larger molecular size and longer half-life
10.1016/s0928-4257(01)00044-4 57 RobertA.NezamisJ
Later in the protocol, you burn through vials rapidly and need consistent supply
